RS_V

Crossed IPO listing price with volumes and retraced

RS_V 업데이트됨   
NSE:WINDLAS   WINDLAS BIOTECH LTD
Windlas Biotech - CDMO. It manufactures medicines for big pharma companies.
Stock price moved above IPO listing price with volumes.
Price retraced and trying to move higher again.

My analysis it is doing similar to Mrs. Bector Foods price movement after it crossed IPO listing price.

If Pharma companies are doing Capex and the sector rotation happens then it should take Windlas higher.

Not a trading but thinking of it is a positional view. I will start investing in very less quantities hoping to make a decent return.

Check fundamentals before investing.


코멘트:
I have a view of one or two years at max. Not for long term holding. There are lot of big CDMO companies in the market Syngene etc.
It might turn negative but I am investing only the amount that I am okay or comfortable to loose.
코멘트:
I am still holding Windlas. Added 13 shares till now.
Windlas competitor Akum Drugs ( CDMO for Cipla, SUN, etc ) filed RHP with SEBI. Usually if an IPO is coming then the prices of the competitors also moves up. This is just an observation not a thumb rule. if market crashes IPOs will not come or IPOs will not perform/subscribe.

Keep a track on this. Not trading or investment call.
면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.